✨ Medicines Act Notices




3376 NEW ZEALAND GAZETTE, No. 130 29 NOVEMBER 2007

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: 3TC
Active Ingredient: Lamivudine 150mg
Dosage Form: White film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Ware, Hertfordshire, United Kingdom

Product: Combivir
Active Ingredients: Lamivudine 150mg
Zidovudine 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers: Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Ware, Hertfordshire, United Kingdom
GlaxoSmithKline Australia Pty Limited, Boronia, Victoria, Australia

Dated this 23rd day of November 2007.

JULIE PATTERSON, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8215

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Rapamune
Active Ingredient: Sirolimus 1mg
Dosage Form: Tablet
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturers: Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, Rouses Point, New York, United States of America

Note: This consent is valid for two years from 22 November 2007.

Product: Rapamune
Active Ingredient: Sirolimus 2mg
Dosage Form: Coated tablet
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturers: Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, Rouses Point, New York, United States of America

Note: This consent is valid for two years from 12 January 2008.

Dated this 23rd day of November 2007.

JULIE PATTERSON, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8214

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Ciloxan Eye Ointment
Active Ingredient: Ciprofloxacin hydrochloride 3.5mg/g equivalent to anhydrous ciprofloxacin base 3mg/g
Dosage Form: Eye ointment
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: SA Alcon Couvreur NV, Puurs, Belgium



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 130


Gazette.govt.nz PDF NZ Gazette 2007, No 130





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
23 November 2007
Medicines, Distribution, Consent, Lamivudine, Zidovudine, GlaxoSmithKline
  • JULIE PATTERSON, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Renewal of Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
23 November 2007
Medicines, Provisional Consent, Renewal, Sirolimus, Rapamune, Wyeth
  • JULIE PATTERSON, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
23 November 2007
Medicines, Distribution, Consent, Ciprofloxacin, Ciloxan, Pacific Pharmaceuticals
  • JULIE PATTERSON, Acting Deputy Director-General, Sector Accountability and Funding Directorate